The Scientist - Home

In the presence of cytosolic DNA, cancer cells activate antiviral pathways that disguise them as immune cells.

Mice treated with an immunostimulant had better outcomes when researchers blocked the expression of TNFR2, a compound that helps tumors evade immune attack.

Mice with cancer whose KRAS proteins couldn’t link together had much better survival outcomes than those whose oncogenic mutant paired with wild-type KRAS.

Motivated by his father’s cancer diagnosis, the Francis Crick Institute cancer geneticist has been revealing the ways tumors evolve and why they are so difficult to treat.

The University of Minnesota researcher is on the front lines in the fight against the disease.

William Halsted’s approach to mastectomy took the medical world by storm at the turn of the last century.

A controversial hypothesis suggests that jellyfish may one day rule the oceans, and Mola mola may tell us if we are approaching a tipping point.

Macrophages play numerous roles within tumors, leaving cancer researchers with a choice: eliminate the cells or recruit them.

The neuronal coverings that mediate synaptic changes are involved in everything from memory to psychiatric disorders, affecting autism, Alzheimer’s, and addiction.

Multidrug combinations lead to better results for cancer patients, but efficiently identifying them is proving difficult.

Negotiations between the publisher and a national consortium of academic institutions have reached a stalemate.

A decade after chytridiomycosis killed scores of amphibians in Panama, some species are recovering. New research indicates why.